Pharmafile Logo
Pharmafocus logo
Advanced Search

stroke

Showing 14 posts of 29 posts found.

Lundbeck scraps stroke drug

December 18, 2014
Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …

News
Pradaxa

Pradaxa ‘safe’ says Australian regulator

August 6, 2014
Research and Development, Sales and Marketing AF, Australia, BMJ, Pradaxa, stroke

Australia’s drug regulator says it will not be updating its safety advice for Boehringer’s Pradaxa despite mounting safety issues around …

News

ReNeuron relocates to Wales

July 22, 2013
Research and Development, Sales and Marketing ReNeuron, Wales, stem cell, stroke

The Welsh government is to fork out a £7.8 million grant package to get English stem cell research company ReNeuron …

News
xbox 360 image

Xbox Kinect technology to help stroke victims

June 19, 2012
Medical Communications Gamification, Roke, Southampton, Xbox, stroke

The University of Southampton and Roke Manor Research have pioneered the use of Microsoft’s Xbox technology to help stroke patients …

News

Petition launched to raise AF and stroke awareness

April 20, 2012
Business Services, Medical Communications, Sales and Marketing AF, Boehringer Ingelheim, Pradaxa, Xarelto, stroke

Various health organisations have called on more people involved in the management of atrial fibrillation (AF) to help raise awareness …

News

Stroke crisis to hit UK unless government acts, warns report

December 5, 2011
Sales and Marketing BMS, Pfizer, Pradaxa, UK, stroke

Major improvements are needed in the treatment of atrial fibrillation to avoid a UK stroke epidemic, according to a new …

News

FDA recommends Xarelto for new approval

September 12, 2011
Sales and Marketing Xarelto, atrial fibrillation, stroke

FDA advisors have recommended Bayer and Johnson & Johnson’s Xarelto be approved in the US for the prevention of stroke …

News

Stem cell trial for stroke is safe

September 1, 2011
Research and Development ReNeuron, Stem cells, stroke

A pioneering stem cell treatment for patients who have suffered a stroke has been ruled safe, and can continue to …

News

UK dementia awareness campaign launched

March 11, 2011
Medical Communications dementia, disease awareness, disease awareness campaigns, stroke

The Department of Health has launched a £1.2 million awareness campaign which aims to alert people to the early signs …

News

Merck suffers late-stage blow to vorapaxar

January 18, 2011
Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar

An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …

News

First patient treated in groundbreaking stem cell trial

November 16, 2010
Research and Development GRNOPC1, Geron, PISCES, Pilot Investigation of Stem Cells in Stroke, ReN001, ReNeuron, Stem cells, ischaemic stroke, stroke

The first patient has been treated in a groundbreaking stem cell trial as part of a bid to develop a …

News

Stroke awareness campaign planned

December 11, 2008
Medical Communications stroke

A three-year campaign to raise awareness of stroke will begin in February, using a mixture of advertising, PR and direct …

News

World’s first stem cell trial for stroke likely to get green light

January 19, 2007
Research and Development ReNeuron, stem cell, stroke

A cutting-edge stem cell clinical trial for chronic stroke patients looks set to go ahead later this year.Biotech company ReNeuron, …

News

AstraZeneca doubles trial size for stroke drug

December 13, 2005
Research and Development AstraZeneca, stroke

 Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026